FDMT vs MRNA · rev $37.0K vs rev $1.94B
4D Molecular Therapeutics Inc (FDMT) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
FDMT currently screens at market cap $518.1M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the FDMT and MRNA stock pages for the full models.
Not investment advice.